today announced it will be added to the Nasdaq Biotechnology Index (Nasdaq: NBI) (the “NBI”). CorMedix’s addition to the NBI will become effective prior to the market open on Monday ...

Health and wealth, indeed. Imagine having the opportunity to invest in a biotech news juggernaut – say, the world’s first antibiotic, penicillin, in the 1940s. “Without penicillin ...

Elaine Chen covers biotech, co-writes The Readout newsletter ... We’ve got several pieces of news relevant to that issue today.

Sanofi need not pay tax on Shantha Biotech buy: High Court The Andhra Pradesh High Court (HC) today said that French drug giant Sanofi Aventis need not pay capital gain tax as demanded by Income ...

IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that one of its scientific co ...

Biotechnology stocks are among the most high-risk, high-reward stocks in the market. Many biotech companies are working to develop one or or even a handful of world-changing drugs to address ...

The U.S. National Security Commission on Emerging Biotechnology (NSCEB) is urging Congress to reinvest in American biotechnology because “the U.S. is dangerously close to falling behind China,” ...

Get your company published in the world ... latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's now and next. Start listening today!

And a new report concludes that Beijing is ascending to biotech dominance ... Get more international news in your inbox with Axios World.

The cyclical, high-risk, high-reward nature of the biotech industry is on full display in 2024. This industry is centered on using living organisms and bioprocesses for innovative drug development ...